GHK-Cu is a naturally occurring copper peptide complex that modulates over 4,000 genes according to the Broad Institute's Connectivity Map project — resetting aged gene expression patterns to youthful profiles. It is one of the most studied peptides in anti-aging dermatology and regenerative medicine.
This peptide profile is for research and educational purposes only. Not intended for human use or self-administration.
Overview
GHK-Cu is a naturally occurring copper peptide complex consisting of the tripeptide Gly-His-Lys bound to a copper(II) ion. It was first identified in human plasma by Dr. Loren Pickart in the 1970s, who discovered that it dramatically stimulated liver tissue repair. GHK-Cu is now one of the most extensively researched peptides in dermatology, wound healing, and anti-aging science, with documented effects on collagen synthesis, antioxidant defense, DNA repair, and over 4,000 gene expression changes catalogued by the Broad Institute's Connectivity Map project — one of the most comprehensive gene-modulating profiles of any known molecule.
Mechanism of Action
GHK-Cu exerts its effects through multiple mechanisms stemming from its ability to coordinate copper ions and facilitate their delivery to copper-dependent enzymes. It activates lysyl oxidase, the enzyme responsible for cross-linking collagen and elastin fibers, dramatically improving the tensile strength and organization of newly synthesized connective tissue. It upregulates chaperone proteins that support protein folding and cellular repair. Through its copper-chelating activity, GHK-Cu acts as a superoxide dismutase (SOD) mimetic — a potent antioxidant protecting against oxidative damage. Analysis of its full gene expression profile reveals that GHK-Cu resets gene activity patterns to those seen in younger tissue: it downregulates genes associated with inflammation, tumor progression, and cellular aging while upregulating genes related to DNA repair, mitochondrial biogenesis, and structural protein synthesis. Additionally, GHK-Cu stimulates VEGF expression and angiogenesis, accelerating wound healing and tissue regeneration.
Key Research
GHK-Cu was first identified by Dr. Loren Pickart (University of California San Francisco) who discovered its remarkable activity in stimulating liver regeneration. The Broad Institute's Connectivity Map project analyzed GHK-Cu's full gene expression profile and catalogued changes in over 4,000 genes — one of the most comprehensive gene regulation profiles of any small molecule studied. Research confirmed GHK-Cu resets gene activity patterns from aged to youthful profiles in multiple tissue types. Double-blind placebo-controlled studies confirmed improvements in skin elasticity, collagen density, and reduction of wrinkles in clinical dermatology trials. Wound healing trials have shown accelerated repair in both acute and chronic wounds. Hair follicle stimulation and reduction of hair loss have been documented in clinical studies.
0.5–2 mg per day (injectable); 1–5% concentration in topical formulations
Half-Life
~30–45 minutes (injectable); hours-long topical activity due
For injectable use, 0.5–2 mg per day subcutaneously is the standard research protocol. A common approach is 1 mg once daily, either injected near target tissues (e.g., face or scalp for cosmetic purposes, joint for cartilage repair) or in the abdomen for systemic effects. For topical application, it is available in professional-grade serums and creams at 1–5% concentration; application once or twice daily to cleansed skin is standard. For wound healing or joint research, peri-lesional injection of 0.5–1 mg daily has been studied. Cycles of 8–12 weeks are typical for injectable use, though topical use can be continued indefinitely. GHK-Cu is frequently combined with BPC-157 for synergistic connective tissue and wound healing protocols.
Anti-Aging Skin Protocol: GHK-Cu topical 2% serum applied twice daily combined with GHK-Cu 1 mg SC weekly for 12 weeks. Connective Tissue Repair Stack: GHK-Cu 1 mg/day + BPC-157 500 mcg/day SC for 8 weeks. Hair Restoration Research: GHK-Cu 1 mg/day SC + topical GHK-Cu applied to scalp 5 days/week for 12 weeks. Longevity Stack: GHK-Cu 0.5 mg/day + Epithalon 10 mg/day (during annual Epithalon course) for combined anti-aging and DNA repair targeting.
Reported Side Effects
Side effects summarized from animal studies and researcher community observations. Educational purposes only — not medical advice.
GHK-Cu has an outstanding safety profile supported by decades of topical and injectable use. Mild redness or irritation at injection sites is occasionally reported, consistent with local copper deposition. Topically, a small percentage of users experience skin irritation or contact sensitization, particularly at concentrations above 5%. Injectable GHK-Cu can occasionally cause a temporary metallic taste — consistent with copper release. At therapeutic doses, copper toxicity is not a concern as the peptide delivers copper in a biologically controlled chelated form, unlike ionic copper supplements. No systemic toxicity, endocrine disruption, or serious adverse events have been documented in research literature.
Storage & Handling
Store GHK-Cu powder at 2–8°C, protected from light. Copper-bound peptides can be sensitive to oxidation — amber vials and limited air exposure are recommended. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 14–21 days. Topical formulations should be stored at room temperature away from direct sunlight and heat. Do not freeze reconstituted GHK-Cu solution as freezing can disrupt the copper-peptide coordination complex.
Age Verification Required
This site contains information about research peptides intended for adults 21 and older. By continuing you confirm you are of legal age in your jurisdiction.
By confirming below, you agree that you are at least 21 years of age and legally able to access this content in your jurisdiction.
Access Restricted
We're sorry, but you must be at least 21 years of age to access this site. This content contains research information intended for adults only.
Research Disclaimer
RESEARCH USE ONLY: All information, tools, and resources on Peptide Oracle are for educational and research purposes only.
Not Medical Advice: Nothing on this website constitutes medical advice, diagnosis, or treatment. This site does not replace professional medical consultation.
Not for Human Consumption: Peptides discussed are for laboratory and research purposes only. They are not approved for human use, consumption, or self-administration.
No Therapeutic Claims: We make no claims regarding the safety, efficacy, or therapeutic benefits of any peptides or compounds discussed.
Legal Compliance: You are responsible for compliance with all applicable local, state, and federal laws regarding peptide research and acquisition.
Limitation of Liability: Peptide Oracle assumes no liability for any damages resulting from use of information provided on this site.
Saved for 30 days. Reset by clearing browser data.
We use cookies to improve your experience and analyse site usage. By clicking Accept All you consent to our use of cookies. Cookie Policy